target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id KCa2.1,381,Q92952,Human,Ca2+,707,,,,,,Activator,Agonist,,yes,,,pEC50,6.52,,6.22,EC50,600.0,,300.0,=,,,,8781233|9774106, KCa2.1,381,Q92952,Human,tubocurarine,2294,,6000,COc1cc2CCN([C@@H]3c2cc1Oc1cc(ccc1O)C[C@@H]1c2c(CC[N+]1(C)C)cc(c(c2Oc1ccc(C3)cc1)O)OC)C,"InChI=1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1",JFJZZMVDLULRGK-URLMMPGGSA-O,Channel blocker,Antagonist,,,,,pIC50,4.6,,4.1,IC50,80000.0,,25000.0,=,,,,8781233|10683185|10696100, KCa2.1,381,Q92952,Human,apamin,2311,,16218850,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N,"InChI=1S/C79H131N31O24S4/c1-35(2)26-49-70(127)107-51-31-136-135-30-41(81)63(120)105-50(28-57(84)114)71(128)108-53(73(130)99-42(12-7-8-22-80)64(121)96-38(5)77(134)110-25-11-15-54(110)75(132)102-47(18-21-58(115)116)69(126)109-59(39(6)111)76(133)95-37(4)62(119)104-49)33-138-137-32-52(106-66(123)44(14-10-24-92-79(88)89)98-65(122)43(13-9-23-91-78(86)87)97-61(118)36(3)94-72(51)129)74(131)101-45(16-19-55(82)112)67(124)100-46(17-20-56(83)113)68(125)103-48(60(85)117)27-40-29-90-34-93-40/h29,34-39,41-54,59,111H,7-28,30-33,80-81H2,1-6H3,(H2,82,112)(H2,83,113)(H2,84,114)(H2,85,117)(H,90,93)(H,94,129)(H,95,133)(H,96,121)(H,97,118)(H,98,122)(H,99,130)(H,100,124)(H,101,131)(H,102,132)(H,103,125)(H,104,119)(H,105,120)(H,106,123)(H,107,127)(H,108,128)(H,109,126)(H,115,116)(H4,86,87,91)(H4,88,89,92)/t36-,37-,38-,39+,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,59-/m0/s1",YVIIHEKJCKCXOB-STYWVVQQSA-N,Inhibitor,None,,,,,pIC50,8.48,,7.92,IC50,12.0,,3.3,=,,,,10683185|15208027|10696100, KCa2.1,381,Q92952,Human,bicuculline,2312,,10237,CN1CCc2c([C@H]1[C@@H]1OC(=O)c3c1ccc1c3OCO1)cc1c(c2)OCO1,"InChI=1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1",IYGYMKDQCDOMRE-ZWKOTPCHSA-N,Channel blocker,Antagonist,,,,,pIC50,,4.8,,IC50,,16000.0,,=,,,,10696100, KCa2.1,381,Q92952,Human,dequalinium,2313,,2993,Nc1cc(C)[n+](c2c1cccc2)CCCCCCCCCC[n+]1c(C)cc(c2c1cccc2)N,"InChI=1S/C30H38N4/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3/p+2",PCSWXVJAIHCTMO-UHFFFAOYSA-P,Channel blocker,Antagonist,,,,,pIC50,,6.4,,IC50,,400.0,,=,,,,10683185|10696100, KCa2.1,381,Q92952,Human,EBIO,2314,,82320,CCn1c(=O)[nH]c2c1cccc2,"InChI=1S/C9H10N2O/c1-2-11-8-6-4-3-5-7(8)10-9(11)12/h3-6H,2H2,1H3,(H,10,12)",CXUCKELNYMZTRT-UHFFFAOYSA-N,Activator,Agonist,,,,2000,,,,,,,,,=,,,,11134030|20359520, KCa2.1,381,Q92952,Human,Lei-Dab7,2315,,16133841,,,,Channel blocker,Antagonist,,,,,pIC50,,5.22,,IC50,,6000.0,,=,,,,11527975, KCa2.1,381,Q92952,Human,leiurotoxin I,2316,,,,,,Channel blocker,Antagonist,,,,,pIC50,7.1,,6.52,IC50,300.0,,80.0,=,,,,10696100|11527975, KCa2.1,381,Q92952,Human,NS309,2317,,135502903,ONC1=c2ccc(c(c2=NC1=O)Cl)Cl,"InChI=1S/C8H4Cl2N2O2/c9-4-2-1-3-6(5(4)10)11-8(13)7(3)12-14/h1-2,14H,(H,11,12,13)",CVOUSAVHMDXCKG-UHFFFAOYSA-N,Activator,Agonist,,,,0.03-0.1,,,,,,,,,=,,,,15471565|20359520, KCa2.1,381,Q92952,Human,NS8593,2318,,11587013,c1ccc2c(c1)[C@@H](CCC2)Nc1nc2c([nH]1)cccc2,"InChI=1S/C17H17N3/c1-2-8-13-12(6-1)7-5-11-14(13)18-17-19-15-9-3-4-10-16(15)20-17/h1-4,6,8-10,14H,5,7,11H2,(H2,18,19,20)/t14-/m1/s1",XZIZUQSOFMLIIR-CQSZACIVSA-N,Gating inhibitor,Antagonist,,,,,pIC50,,6.4,,IC50,,400.0,,=,,,,16926279, KCa2.1,381,Q92952,Human,tamapin,2319,,,,,,Channel blocker,Antagonist,,,,,pIC50,,7.4,,IC50,,40.0,,=,,,,12239213, KCa2.1,381,Q92952,Human,UCL1684,2320,,656733,c1cc2cc(c1)C[n+]1ccc(c3c1cccc3)NCc1ccc(CNc3cc[n+](C2)c2ccccc32)cc1,"InChI=1S/C34H28N4/c1-3-10-33-29(8-1)31-16-18-37(33)23-27-6-5-7-28(20-27)24-38-19-17-32(30-9-2-4-11-34(30)38)36-22-26-14-12-25(13-15-26)21-35-31/h1-20H,21-24H2/p+2",HZWVJPDDZQOYGA-UHFFFAOYSA-P,Inhibitor,None,,,,,pIC50,,9.1,,IC50,,0.8,,=,,,,10696100|20359520, KCa2.1,381,Q92952,Human,UCL1848,2321,,9811445,C1CCNc2cc[n+](c3c2cccc3)CCCCC[n+]2ccc(NCC1)c1ccccc21,"InChI=1S/C28H32N4/c1-7-17-29-25-15-21-31(27-13-5-3-11-23(25)27)19-9-2-10-20-32-22-16-26(30-18-8-1)24-12-4-6-14-28(24)32/h3-6,11-16,21-22H,1-2,7-10,17-20H2/p+2",IOXVWOJJNCBJBX-UHFFFAOYSA-P,Channel blocker,Antagonist,,,,,pIC50,,9.0,,IC50,,1.0,,=,,,,10683185, KCa2.1,381,Q92952,Human,riluzole,2326,,5070,Nc1nc2c(s1)cc(cc2)OC(F)(F)F,"InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)",FTALBRSUTCGOEG-UHFFFAOYSA-N,Activator,Agonist,,,,,pEC50,,4.68,,EC50,,21000.0,,=,,,,18955585, KCa2.1,381,Q92952,Human,SKA-31,2335,,94880,Nc1nc2c(s1)ccc1c2cccc1,"InChI=1S/C11H8N2S/c12-11-13-10-8-4-2-1-3-7(8)5-6-9(10)14-11/h1-6H,(H2,12,13)",FECQXVPRUCCUIL-UHFFFAOYSA-N,Activator,Agonist,,,,,pEC50,,5.54,,EC50,,2900.0,,=,,,,18955585, KCa2.1,381,Q92952,Human,tetraethylammonium,2343,,5413,CC[N+](CC)(CC)CC,"InChI=1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1",CBXCPBUEXACCNR-UHFFFAOYSA-N,Channel blocker,None,,,,,pIC50,,2.7,,,,,,=,,,,20359520, KCa2.1,381,Q92952,Human,SKA-20,9312,,90872293,Nc1nc2c(s1)c1cc3ccccc3cc1cc2,"InChI=1S/C15H10N2S/c16-15-17-13-6-5-11-7-9-3-1-2-4-10(9)8-12(11)14(13)18-15/h1-8H,(H2,16,17)",YKXKYTRQOWDNGL-UHFFFAOYSA-N,Activator,Agonist,,,,,pEC50,,6.37,,EC50,,430.0,,=,,,,18955585, KCa2.1,381,Q92952,Human,GW542573X,9313,,24885053,COc1ccccc1NC(=O)OCC1CCN(CC1)C(=O)OC(C)(C)C,"InChI=1S/C19H28N2O5/c1-19(2,3)26-18(23)21-11-9-14(10-12-21)13-25-17(22)20-15-7-5-6-8-16(15)24-4/h5-8,14H,9-13H2,1-4H3,(H,20,22)",SAXGSDIZIYFNKD-UHFFFAOYSA-N,Activator,Agonist,,,,,pEC50,,5.09,,EC50,,8200.0,,=,,,,19515965, KCa2.1,381,Q92952,Human,CM-TPMF,9314,,3780244,CON=CNc1nn2c(n1)nccc2C(Oc1ccc(cc1C)Cl)C,"InChI=1S/C16H17ClN6O2/c1-10-8-12(17)4-5-14(10)25-11(2)13-6-7-18-16-21-15(22-23(13)16)19-9-20-24-3/h4-9,11H,1-3H3,(H,19,20,22)",OZWWQEQUDKBSCF-UHFFFAOYSA-N,Activator,Agonist,,,,,pEC50,,7.62,,EC50,,24.0,,=,,,,22046005, KCa2.1,381,Q92952,Human,B-TPMF,9315,,4436121,CON=CNc1nn2c(n1)nccc2C(Oc1ccc(cc1)C(C)(C)C)C,"InChI=1S/C19H24N6O2/c1-13(27-15-8-6-14(7-9-15)19(2,3)4)16-10-11-20-18-23-17(24-25(16)18)21-12-22-26-5/h6-13H,1-5H3,(H,21,22,24)",HJKSIPKXGWOSBM-UHFFFAOYSA-N,Gating inhibitor,Antagonist,,,,,pEC50,,7.51,,EC50,,31.0,,=,,,,22046005,